Trials / Unknown
UnknownNCT03345056
Vitrectomy With Planned Foveal Detachment for Refractory DME With or Without Vitreo-macular Interface Abnormality
Evaluation of Vitrectomy With Planned Foveal Detachment as Surgical Treatment for Refractory Diabetic Macular Edema With or Without Vitreo-macular Interface Abnormality
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (estimated)
- Sponsor
- Ministry of Health and Population, Egypt · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the therapeutic efficacy of sub retinal BSS injections in conjunction with conventional vitrectomy for refractory Diabetic macular edema (DME)- resistant to more than one anti-VEGF agent, intravitreal corticosteroids and to previous vitrectomy. Some of enrolled cases had normal vitreo-macular interface (VMI) relationship, while other cases had incomplete vitreoretinal separation with vitreomacular attachment (VMA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | vitrectomy with planned foveal detachment | 23 gauge vitrectomy, posterior hyaloid detachment, internal limiting membrane peeling , sub-macular BSS injection using 38 gauge canula |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2017-11-01
- Completion
- 2017-11-01
- First posted
- 2017-11-17
- Last updated
- 2017-11-17
Source: ClinicalTrials.gov record NCT03345056. Inclusion in this directory is not an endorsement.